Citigroup
AGIO icon

Citigroup’s Agios Pharmaceuticals AGIO Stock Holding History

Citigroup’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.13M Buy
62,900
+33,000
+110% +$936K ﹤0.01% 2628
2025
Q4 		$814K Buy
+29,900
New +$1.05M ﹤0.01% 3268
2025
Q2 		– Sell
-60,000
Closed -$1.76M – 5632
2025
Q1 		$1.76M Buy
60,000
+30,000
+100% +$995K ﹤0.01% 2815
2024
Q4 		$986K Buy
30,000
+4,300
+17% +$202K ﹤0.01% 3380
2024
Q3 		$1.14M Buy
+25,700
New +$1.17M ﹤0.01% 3163
2024
Q2 		– Sell
-26,800
Closed -$784K – 5561
2024
Q1 		$784K Sell
26,800
-2,000
-7% -$53.6K ﹤0.01% 3218
2023
Q4 		$641K Sell
28,800
-29,900
-51% -$670K ﹤0.01% 3219
2023
Q3 		$1.45M Buy
58,700
+28,800
+96% +$762K ﹤0.01% 2231
2023
Q2 		$847K Buy
29,900
+100
+0.3% +$2.49K ﹤0.01% 2970
2023
Q1 		$685K Sell
29,800
-30,200
-50% -$802K ﹤0.01% 2872
2022
Q4 		$1.68M Buy
60,000
+10,400
+21% +$293K ﹤0.01% 2176
2022
Q3 		$1.4M Buy
49,600
+30,000
+153% +$805K ﹤0.01% 2448
2022
Q2 		$435K Sell
19,600
-10,400
-35% -$235K ﹤0.01% 3336
2022
Q1 		$873K Buy
+30,000
New +$917K ﹤0.01% 3097
2021
Q1 		– Sell
-1,000
Closed -$43K – 6181
2020
Q4 		$43K Hold
1,000
– – ﹤0.01% 6137
2020
Q3 		$35K Sell
1,000
-38,700
-97% -$1.7M ﹤0.01% 5812
2020
Q2 		$2.12M Buy
39,700
+1,700
+4% +$78.7K ﹤0.01% 2745
2020
Q1 		$1.35M Sell
38,000
-10,400
-21% -$481K ﹤0.01% 2862
2019
Q4 		$2.31M Sell
48,400
-4,200
-8% -$159K ﹤0.01% 2824
2019
Q3 		$1.7M Sell
52,600
-9,000
-15% -$373K ﹤0.01% 3037
2019
Q2 		$3.07M Buy
61,600
+23,800
+63% +$1.27M ﹤0.01% 2378
2019
Q1 		$2.55M Buy
37,800
+21,800
+136% +$1.27M ﹤0.01% 2420
2018
Q4 		$738K Sell
16,000
-3,500
-18% -$216K ﹤0.01% 3710
2018
Q3 		$1.5M Sell
19,500
-3,200
-14% -$257K ﹤0.01% 3036
2018
Q2 		$1.91M Buy
22,700
+3,200
+16% +$279K ﹤0.01% 2709
2018
Q1 		$1.59M Buy
19,500
+9,000
+86% +$696K ﹤0.01% 2807
2017
Q4 		$600K Buy
10,500
+4,000
+62% +$252K ﹤0.01% 3911
2017
Q3 		$434K Sell
6,500
-2,000
-24% -$120K ﹤0.01% 4259
2017
Q2 		$437K Buy
8,500
+1,300
+18% +$66.5K ﹤0.01% 4111
2017
Q1 		$420K Buy
7,200
+2,700
+60% +$129K ﹤0.01% 4022
2016
Q4 		$188K Sell
4,500
-6,800
-60% -$357K ﹤0.01% 5331
2016
Q3 		$597K Buy
11,300
+10,000
+769% +$435K ﹤0.01% 3737
2016
Q2 		$54K Sell
1,300
-16,000
-92% -$790K ﹤0.01% 5519
2016
Q1 		$702K Buy
17,300
+4,100
+31% +$175K ﹤0.01% 3756
2015
Q4 		$857K Buy
13,200
+300
+2% +$19.7K ﹤0.01% 3308
2015
Q3 		$911K Sell
12,900
-10,200
-44% -$997K ﹤0.01% 3178
2015
Q2 		$2.57M Buy
+23,100
New +$2.49M ﹤0.01% 2301

Other funds holding AGIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Citigroup's AGIO Position: Q1 2026 in Review

Citigroup reduced its Agios Pharmaceuticals (AGIO) stake by 81% in Q1 2026, selling an estimated $2.02M and leaving 17,096 shares worth $578K. The position accounts for ﹤0.01% of the portfolio, ranked #3458.

Citigroup first reported a position in AGIO in Q3 2013 and has held it in 50 quarters since. The position peaked at $7.77M in Q3 2020. 233 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

  • Citigroup held 17,096 shares of Agios Pharmaceuticals worth $578K as of Q1 2026.
  • Citigroup sold 71,142 Agios Pharmaceuticals shares in Q1 2026, an estimated $2.02M.
  • Agios Pharmaceuticals made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #3458 holding.
  • Citigroup first reported a position in Agios Pharmaceuticals in Q3 2013 and has held it in 50 quarters since.
  • Citigroup's Agios Pharmaceuticals position peaked at $7.77M in Q3 2020.
  • 233 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.